Tag
13 posts tagged “Blood sugar”.
A measured, harm-reduction look at orforglipron, a non-peptide GLP-1 pill approved for obesity, and what actually matters to track.
A neutral, harm-reduction guide to the oral semaglutide weight-management pill, its strict dosing rules, and what to monitor.
A neutral, harm-reduction guide to mazdutide, a dual glucagon/GLP-1 agonist approved in China, and what to monitor.
Why insulin is the most dangerous peptide on the menu, and how serious users approach tracking when medically indicated.
A tracking guide for metformin that takes its prescription status and side effects seriously.
Weekly GLP-1 receptor agonist with a clean titration shape — what to track and how it compares to semaglutide and tirzepatide.
A focused guide to tracking a tirzepatide protocol — the titration, the unique GIP-side effects, sulfur burps, and what to log week-over-week.
A pragmatic guide to logging a semaglutide titration. What to capture daily, weekly, and at every dose increase.
The first-in-class GLP-1 receptor agonist, derived from Gila monster venom — twice-daily and weekly versions tracked.
What cagrilintide is, why it is being studied with semaglutide as CagriSema, and how to track appetite, weight, and tolerability.
How to log a liraglutide titration and decide whether the daily-injection tradeoff makes sense for you.
What Retatrutide is, how the GLP-1 / GIP / glucagon mechanism differs from single-agonists, and how to track titration and side effects honestly.
The two leading GLP-1 protocols compared by what they ask of the user, what to track, and how the side-effect profiles differ across a titration.